Spring Bank Pharmaceuticals, Inc. (SBPH)

Trade SBPH now with
10/31/2017 6:55:13 AM Spring Bank Pharma Q3 Loss Widens To $10.8 Mln Or $0.85/shr From $4.1 Mln Or $0.53/shr Last Year
7/10/2017 8:36:03 AM Spring Bank Collaborates With Gilead For Hepatitis B Phase 2 Study Exploring Treatment Of SB 9200 And Vemlidy
6/22/2017 9:06:56 AM Spring Bank Pharmaceuticals Prices Public Offering Of 2.88 Mln Shares At $13/Shr
6/21/2017 4:04:34 PM Spring Bank Pharma Announces Proposed Public Offering Of Common Stock
6/7/2017 7:08:46 AM Spring Bank Announces Publication Of An Abstract At ASCO Related To Its Lead STING Agonist Candidate, SB 11285
4/28/2017 8:37:11 AM Spring Bank Pharma Q1 Net Loss $6.5 Mln Or $0.69/shr Vs. Net Loss $6.5 Mln Or $1.11/shr Last Year
2/15/2017 8:08:22 AM Spring Bank Pharmaceuticals Q4 Loss/shr $0.28 Vs. Loss/shr $0.68 Last Year
12/19/2016 7:08:34 AM Spring Bank And Arbutus Biopharma Announce Preclinical Collaboration In Study Of Chronic Hepatitis B
10/20/2016 7:36:37 AM Spring Bank Pharma Presents Data On STING Agonist SB 11285 At AACR Special Conference
10/6/2016 7:41:07 AM Arrowhead And Spring Bank Announce Clinical Collaboration For ARC-520 And SB 9200 In Chronic Hepatitis B